SCHEMBL6298097

SCHEMBL6298097

COc1ccc(C(N)(C(=O)OCC2c3ccccc3-c3ccccc32)c2ccc(CC(=O)O)cc2)c(OC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FABP5 Q01469 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.38
▸ TP53 P04637 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ AKR1C3 P42330 1/20 0.38
▸ AKR1C2 P52895 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ GPR55 Q9Y2T6 1/20 0.36
▸ NR1H4 Q96RI1 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ PPARD Q03181 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28069714 0.92 FABP5 (0.45) FABP5ALDH1A1TP53MAPTMEN1
SCHEMBL8752790 0.89 NPC1 (0.41) FABP5MEN1KMT2ATSHRGPR55
SCHEMBL3485726 0.89 FABP5 (0.41) FABP5ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL28191790 0.86 NPC1 (0.39) FABP5ALDH1A1MAPTMEN1KMT2A
SCHEMBL30679137 0.82 NPC1 (0.44) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL7867953 0.79 FABP5 (0.39) FABP5TP53PTGS1AKR1C3AKR1C2
SCHEMBL29521535 0.79 MEN1 (0.49) ALDH1A1TP53MAPTMEN1KMT2A
SCHEMBL27082137 0.79 NPC1 (0.40) FABP5ALDH1A1TP53MAPTL3MBTL1
SCHEMBL29385536 0.78 KMT2A (0.43) FABP5ALDH1A1TP53MAPTMEN1
SCHEMBL31013146 0.78 KMT2A (0.34) FABP5MAPTL3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6946562-B2 Synthesis of peptoid substituted azole compounds EASTMAN KODAK COMPANY (US) 2005-09-20 — — US disclosed
US-20030187188-A1 Synthesis of peptoid substituted azole compounds EASTMAN KODAK COMPANY 2003-10-02 — — US disclosed
EP-1319975-A1 Synthesis of peptoid substituted azole compounds EASTMAN KODAK COMPANY (US) 2003-06-18 — — EP disclosed
EP-1319979-A1 Imaging materials containing peptoid substituted azole couplers EASTMAN KODAK COMPANY (US) 2003-06-18 — — EP disclosed
US-6514679-B1 Imaging materials containing peptoid substituted azole couplers EASTMAN KODAK COMPANY 2003-02-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187188-A1 Synthesis of peptoid substituted azole compounds ERG28, MLNR, DNPEP FABP5 650/4885ALDH1A1 4662/4885TP53 2346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback